|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,590.00 GBX | +0.63% |
|
+1.92% | -20.22% |
| 11-26 | Stocks rise, pound firms after "tolerable" budget | AN |
| 11-20 | Hikma Pharmaceuticals, DGI Group Enter Licensing Deal for Skin Tag Removal Device | MT |
| Capitalization | 4.7B 4.03B 3.77B 3.52B 6.56B 422B 7.1B 44.23B 17.07B 200B 17.64B 17.27B 728B | P/E ratio 2025 * |
11x | P/E ratio 2026 * | 9.82x |
|---|---|---|---|---|---|
| Enterprise value | 5.7B 4.89B 4.57B 4.27B 7.95B 512B 8.61B 53.64B 20.7B 242B 21.4B 20.94B 882B | EV / Sales 2025 * |
1.71x | EV / Sales 2026 * | 1.57x |
| Free-Float |
65.88% | Yield 2025 * |
3.83% | Yield 2026 * | 4.11% |
Last Transcript: Hikma Pharmaceuticals PLC
| 1 day | +0.63% | ||
| 1 week | +1.92% | ||
| Current month | +2.32% | ||
| 1 month | -12.69% | ||
| 3 months | -8.67% | ||
| 6 months | -25.35% | ||
| Current year | -20.22% |
| 1 week | 1,552 |  | 1,611 |
| 1 month | 1,522 | | 1,781 |
| Current year | 1,522 | | 2,360 |
| 1 year | 1,522 | | 2,360 |
| 3 years | 1,471.5 | | 2,360 |
| 5 years | 1,174.5 | | 2,703 |
| 10 years | 814.2 | | 2,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
Riad Mishlawi
CEO | Chief Executive Officer | 61 | 31/08/2023 |
Khalid Nabilsi
DFI | Director of Finance/CFO | 53 | 31/12/2000 |
Hill Julie
CMP | Compliance Officer | - | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 68 | 13/10/2005 | |
Said Darwazah
CHM | Chairman | 68 | 14/05/2014 |
Riad Mishlawi
BRD | Director/Board Member | 61 | 31/12/1989 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.44% | 1,096 M€ | +28.54% | - |
| 0.25% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.63% | +1.92% | -18.96% | +3.96% | 4.67B | |
| -1.85% | -8.14% | +24.73% | +170.70% | 925B | |
| -1.39% | -2.45% | +32.90% | +13.19% | 495B | |
| -0.66% | +0.46% | +26.01% | +39.75% | 407B | |
| -1.18% | -0.89% | +21.85% | +0.60% | 335B | |
| -1.31% | -4.48% | +25.25% | +20.90% | 283B | |
| -0.48% | +1.50% | +14.90% | +27.03% | 257B | |
| -1.35% | -3.57% | -0.94% | -8.32% | 254B | |
| +0.66% | -2.67% | -60.91% | -31.82% | 211B | |
| -1.52% | -1.28% | +22.22% | +19.14% | 186B | |
| Average | -0.30% | -1.13% | +8.70% | +25.51% | 335.85B | |
| Weighted average by Cap. | -0.46% | -2.24% | +17.58% | +56.13% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.33B 2.85B 2.67B 2.49B 4.64B 299B 5.03B 31.3B 12.08B 141B 12.49B 12.22B 515B | 3.51B 3.01B 2.82B 2.63B 4.9B 316B 5.31B 33.06B 12.76B 149B 13.19B 12.91B 544B |
| Net income | 442M 379M 355M 331M 617M 39.72B 668M 4.16B 1.61B 18.77B 1.66B 1.62B 68.43B | 477M 409M 383M 358M 666M 42.88B 721M 4.49B 1.73B 20.26B 1.79B 1.75B 73.89B |
| Net Debt | 1B 858M 802M 749M 1.39B 89.84B 1.51B 9.41B 3.63B 42.45B 3.75B 3.67B 155B | 810M 695M 650M 607M 1.13B 72.78B 1.22B 7.62B 2.94B 34.39B 3.04B 2.98B 125B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/12/25 | 1,590.00 p | +0.63% | 279,053 |
| 03/12/25 | 1,580.00 p | +0.13% | 493,700 |
| 02/12/25 | 1,578.00 p | +0.19% | 446,206 |
| 01/12/25 | 1,575.00 p | +1.35% | 469,414 |
| 28/11/25 | 1,554.00 p | -1.02% | 538,326 |
Delayed Quote London S.E., December 04, 2025 at 04:35 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition